Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease-Reference-Cited by-同舟云学术

Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease

Published:2022-02-25 Issue:8 Volume:101 Page:e28994
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Lv Lina,Yuan Xianying,Jiang Lihong

Funder

Natural Science Foundation of Jilin Province

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference14 articles.

1. Clinical applicability of coronary atherosclerotic lesion characterization;Kaluski;Minerva Cardioangiol,2011

2. Psychological stress, inflammation, and coronary heart disease;Wirtz;Curr Cardiol Rep,2017

3. Recognizing global burden of cardiovascular disease and related chronic diseases;Kelly;Mt Sinai J Med,2012

4. Percutaneous coronary intervention in 2018;Bhatt;JAMA,2018

5. Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention;Hamasaki;J Cardiol,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of network pharmacology, UHPLC-Q exactive orbitrap HRMS technique and metabolomics to elucidate the active ingredients and mechanisms of compound danshen pills in treating hypercholesterolemic rats;Journal of Ethnopharmacology;2025-01

2. Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects;Frontiers in Pharmacology;2024-06-07

3. Research progress on the mechanism of anti-myocardial infarction effect and clinical application of effective components of Salvia miltiorrhiza;Medicinal Chemistry Research;2023-12-30

4. Dihydrotanshinone I-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism;Drug Metabolism and Disposition;2023-12-15

5. Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials;Chinese Medicine;2023-12-13